Who owns UroGen Pharma Ltd., from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).
Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.
The Toronto-Dominion Bank: 6.7% · 3,269,957 shares — TD SECURITIES INC.: 0.2% · 101,306 shares
Paradigm BioCapital Advisors LP: 3.5% · 1,703,949 shares — Paradigm BioCapital Advisors GP LLC: 3.5% · 1,703,949 shares — Senai Asefaw, M.D.: 3.5% · 1,703,949 shares
8 more 5% stakes behind a free account
See every investor who has disclosed crossing 5% of UroGen Pharma Ltd..
Sign up freeEvery institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of UroGen Pharma Ltd. they hold. Together these 229 managers report 99.78% of shares outstanding.
| Investor | Position value | Shares | % of their portfolio | % of company | As of |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | $167M | 4,543,895 | 1.43% | 9.30% | June 30, 2026 |
| BlackRock, Inc. | $118M | 3,201,461 | 0.00% | 6.55% | June 30, 2026 |
227 more institutional holders behind a free account
See every manager reporting UroGen Pharma Ltd., how much of the company they hold, and how big the position is inside their own portfolio.
Sign up freeFunds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 50 funds hold 3.66% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.
| Fund | Position value | % of net assets | % of company | As of |
|---|---|---|---|---|
| Small Cap Growth Fund | $20.9M | 0.41% | 1.79% | April 30, 2026 |
| VANGUARD RUSSELL 2000 INDEX FUND | $3.97M | 0.03% | 0.37% | February 28, 2026 |
48 more funds behind a free account
See every fund holding UroGen Pharma Ltd. and what share of its net assets the position represents.
Sign up freeLoading...
